peptide elispot designed to stimulate T cells - peptide-english The ELISpot assay is a powerful in vitro immunoassay Unveiling Cellular Immunity: A Deep Dive into the Peptide ELISPOT Assay

peptide-enthusiast The peptide ELISPOT assay stands as a cornerstone in immunology research, offering a highly sensitive and quantitative method for detecting and measuring cellular immune responses. At its core, this powerful in vitro immunoassay enables researchers to determine the frequency of cells within a population that are actively secreting specific cytokines. This capability is critical for understanding immunity against pathogens, evaluating vaccine efficacy, and monitoring responses to therapeutic interventions, particularly those involving peptides.

The ELISPOT assay is fundamentally designed to measure the frequency of cytokine-secreting cells at the single-cell level. This granular level of detail sets it apart from other immunological techniques, providing a direct count of effector cells. While the ELISPOT can detect various cytokines, a prominent application is the measurement of Interferon-gamma (IFN-γ). IFN-γ is a pivotal cytokine crucial for effective immunity against intracellular pathogens and plays a significant role in tumor control, predominantly produced by natural killer (NK) cells and T cells. Therefore, an IFN-gamma ELISPOT assay is frequently employed to assess cell-mediated immunity.

A key aspect of utilizing the peptide ELISPOT is the preparation and use of peptides as stimulatory agents. Researchers often need to prepare peptide pool stocks and PBMC suspensions to initiate the assay. The choice of peptide length is also a critical parameter2023年9月4日—ABSTRACT. 18. 19.The ELISpot assay is a powerful in vitro immunoassaythat enables cost-effective quantification.. For instance, studies suggest using 29-mer peptides for both CD8 and CD4 stimulations, while others advocate for the minimal MHC-I epitope (8 to 10-mer) for CD8 stimulation and shorter 15-mer peptides for CD4 stimulation. When preparing the assay, it's common practice to dilute stock solution of peptide(s) to 2x final concentration with T-cell medium. Furthermore, the inclusion of control peptide pools, such as CEF or CMVpp65, is essential for quality control and validation of the assayPoorly soluble peptides can mimic authentic ELISPOT .... In some ELISpot analysis, the use of irrelevant peptides as negative controls is also considered to ensure specificity of the observed responses.

The ELISpot (Enzyme-Linked ImmunoSpot) technique is recognized as a flexible and sensitive method for investigating the frequency of cytokine-secreting cells.2022年11月24日—The peptides contain MHC class I-restricted T-cell epitopes from CMV, EBV and Influenza virus,designed to stimulate T cellsfrom donors with a ... Its quantitative nature allows for the precise enumeration of antigen-specific T cells. For example, an ELISPOT assay can be used to detect specific reaction of T cells to EBV peptide segments in patients, providing valuable insights into their immune statusOptimizing Combinatorial Design of Pooled ELISpot .... The assay's ability to detect responses to specific epitopes makes it invaluable in fields like vaccine development and cancer immunotherapy, where targeted immune responses are paramount.Top ELISpot Assay Services The ELISPOT assay has been instrumental in measuring human immune responses to vaccines and assessing the immunogenicity of peptide drugs.

The methodology of the peptide ELISPOT assay involves incubating peripheral blood mononuclear cells (PBMCs) with specific peptides in a specialized plate coated with antibodies against the cytokine of interestELISPOT Assay to Detect Specific Reaction of T Cells to EBV Peptide Segmentsfor Patients with Nasopharyngeal Carcinoma before and after Radiotherapy[J].. Following incubation, cells that have secreted the cytokine are captured by the antibody and detected using a secondary antibody conjugated to an enzyme. This enzyme catalyzes a colorimetric reaction, resulting in the formation of visible spots, each representing a single cytokine-secreting cell. The number of spots is then counted, providing a quantitative measure of the antigen-specific immune response.

Validation of an IFN-gamma ELISpot assay is a crucial step to ensure reliable and reproducible results.ELISPOT Assay to Detect Specific Reaction of T Cells to EBV Peptide Segmentsfor Patients with Nasopharyngeal Carcinoma before and after Radiotherapy[J]. This involves meticulous optimization of various parameters, including cell numbers, peptide concentration, and incubation times.29-mer peptides for both CD8 and CD4 stimto using the minimal MHC-I epitope (8 to 10-mer) for CD8 stim and the shorter 15-mer peptides for CD4 stim. For instance, one might investigate whether it is better to increase the number of cells plated or increase the peptide concentration to enhance signaling.作者：MN Wykes·2017·被引用次数：15—The enzyme-linked immunospot (ELISPOT) assay is a highly sensitive immunoassay thatmeasures the frequency of cytokine-secreting cells at the single-cell level. Moreover, the ELISpot analysis was done triplicated for each peptide to ensure statistical robustness.作者：H Liu·2019·被引用次数：1—TheELISpot analysis was done triplicated for each peptide. The mean number of spots was adjusted to 1×106. PBMC. 2.4 IFN-γ measurement by ELISA assay. The IFN- ... The development of standardized protocols and quality controls, such as using a panel of MHC Class I-restricted viral peptides as a quality control for vaccine trials, further enhances the reliability of the peptide ELISPOT assayMethods for Assessing the Immunogenicity of Peptide Drugs ....

In summary, the peptide ELISPOT assay is a sophisticated yet accessible tool for dissecting cellular immunity.ELISPOT Assay to Detect Specific Reaction of T Cells to EBV Peptide Segmentsfor Patients with Nasopharyngeal Carcinoma before and after Radiotherapy[J]. Its ability to quantify cytokine production at the single-cell level, particularly IFN-γ, in response to specific peptide stimulation, makes it indispensable for a wide range of immunological research, from fundamental discovery to clinical applications. The continuous refinement of ELISPOT methodologies and the exploration of new peptide designs promise to further expand its utility in understanding and manipulating the immune system.